| Model Number |
ONYXNG30022UX |
| Medical Device Problem Codes |
Device Dislodged or Dislocated (2923); Material Deformation (2976); Positioning Problem (3009)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/18/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
An attempt was made to use one onyx frontier coronary drug-eluting stent to treat a lesion with high grade stenosis in the left anterior descending (lad) artery.The lesion was pre-dilated.Resistance was not encountered when advancing the device.Excessive force was not used during delivery.It was reported that the stent failed to cross/position the lesion and stent dislodgement occurred.It was detailed that the onyx frontier was attempted to be delivered in the lad however, it was removed for further pre-dilation of the lesion.After pre-dilation was complete, it was attempted to deliver the stent again.When ready to deploy, it was noted that the stent was not on the catheter.The catheter was removed and there was no stent on the balloon.The dislodged stent did not remain in patient.It was detailed that when searching the sterile table, the stent was found lying on the sterile table.The patient is alive with no injury.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: there was no damage noted to the packaging.The lesion was pre-dilated.Resistance was not noted during the withdrawal of the device.The stent was believed to have fallen off the balloon when it was back on the table and not in the patient.When the catheter was inserted into the lesion, before deployment, it was found that the stent was lying on the table where the catheter had been.The dislodged stent remained intact and did not detach/break into two pieces.A new stent was used to complete the procedure.There was no injury to the patient as a result of the event.Patient weight and gender provided.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
Product analysis summary: the stent was not present on the balloon but did return for analysis.Deformation was evident to the returned stent struts.The balloon folds were expanded.Crimp impressions were visible on the exposed balloon surface.No deformation evident to the distal tip.No other damage evident to the remainder of the device.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|